Bioprocess Technology Market Projected to Triple by 2035

  • The global bioprocess technology market is projected to grow from USD 55.63 billion in 2025 to USD 134.06 billion by 2035, representing a CAGR of 9.19%.
  • North America held the largest regional share at 40.0% in 2025, while Asia Pacific is expected to record the fastest growth at 10.38% annually.
  • Consumables and accessories represented 62.0% of product revenue in 2025, with downstream processing accounting for 54.0% of process revenue.
  • Fed-batch technology dominated with 58.0% of technology revenue in 2025, while continuous processing is the fastest-growing technology category at a modeled 12.56% CAGR.

The bioprocess technology market is poised for significant growth driven by expanding biologic capacity and the shift toward single-use workflows. The dominance of consumables and downstream processing highlights the recurring revenue potential for suppliers. Strategic acquisitions, such as Thermo Fisher's USD 4 billion purchase of Solventum's filtration business, underscore the competitive landscape's focus on integrated production workflows.

Regional Dynamics
How the fastest growth in Asia Pacific at 10.38% CAGR will impact global market share and supplier strategies.
Technology Shifts
Whether continuous processing can sustain its 12.56% CAGR and challenge fed-batch dominance.
Supplier Consolidation
The pace at which major players like Thermo Fisher will integrate acquisitions like Solventum to expand their product ranges.